Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "heterogeneous nuclear ribonucleoprotein D-like pseudogene" (ENSG00000226843) is a catalogued human pseudogene. Pseudogenes are typically nonfunctional remnants of genes that have lost their protein-coding potential due to mutations. They are often transcriptionally inactive and do not produce proteins. This entry should not be confused with the functional heterogeneous nuclear ribonucleoprotein D-like (HNRPDL, gene symbol HNRNPDL), which is an RNA-binding protein involved in mRNA processing and is linked to limb-girdle muscular dystrophy when mutated[1][3]. ENSG00000226843 does not encode an active protein and is not a relevant therapeutic target. This entity is a *pseudogene*, not a valid target. Data for "Heterogeneous nuclear ribonucleoprotein D-like" (HNRNPDL protein, not pseudogene) should not be mapped here. Entries for target mapping should exclude pseudogenes unless specifically involved in disease or regulatory phenomena, which is not the case for ENSG00000226843 in current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein D-like pseudogene.